123 related articles for article (PubMed ID: 7910123)
1. Increased ICAM-1 expression in the early stages of murine chronic graft-versus-host disease.
Schiltz PM; Giorno RC; Claman HN
Clin Immunol Immunopathol; 1994 May; 71(2):136-41. PubMed ID: 7910123
[TBL] [Abstract][Full Text] [Related]
2. Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
Eyrich M; Burger G; Marquardt K; Budach W; Schilbach K; Niethammer D; Schlegel PG
Biol Blood Marrow Transplant; 2005 May; 11(5):371-82. PubMed ID: 15846291
[TBL] [Abstract][Full Text] [Related]
3. Contribution of CD11a/CD18, CD11b/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers.
Shang XZ; Issekutz AC
Eur J Immunol; 1998 Jun; 28(6):1970-9. PubMed ID: 9645379
[TBL] [Abstract][Full Text] [Related]
4. Role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 during nonsuppurative destructive cholangitis in a mouse graft-versus-host disease model.
Howell CD; Li J; Chen W
Hepatology; 1999 Mar; 29(3):766-76. PubMed ID: 10051478
[TBL] [Abstract][Full Text] [Related]
5. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue.
Nakajima H; Sano H; Nishimura T; Yoshida S; Iwamoto I
J Exp Med; 1994 Apr; 179(4):1145-54. PubMed ID: 7511681
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses.
de Fougerolles AR; Qin X; Springer TA
J Exp Med; 1994 Feb; 179(2):619-29. PubMed ID: 7905020
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
Goedegebuure PS; Braakman E; Segal DM; Vreugdenhil RJ; Bolhuis RL
Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
[TBL] [Abstract][Full Text] [Related]
9. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.
Ilan Y; Gotsman I; Pines M; Beinart R; Zeira M; Ohana M; Rabbani E; Engelhardt D; Nagler A
Blood; 2000 Jun; 95(11):3613-9. PubMed ID: 10828052
[TBL] [Abstract][Full Text] [Related]
10. The role of LFA-1/ICAM-1 interactions during murine T lymphocyte development.
Fine JS; Kruisbeek AM
J Immunol; 1991 Nov; 147(9):2852-9. PubMed ID: 1680920
[TBL] [Abstract][Full Text] [Related]
11. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
Tohma S; Hirohata S; Lipsky PE
J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
[TBL] [Abstract][Full Text] [Related]
12. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
Howell CD; Yoder T; Claman HN; Vierling JM
J Immunol; 1989 Jul; 143(2):476-83. PubMed ID: 2472440
[TBL] [Abstract][Full Text] [Related]
13. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase.
Arroyo AG; Campanero MR; Sánchez-Mateos P; Zapata JM; Ursa MA; del Pozo MA; Sánchez-Madrid F
J Cell Biol; 1994 Sep; 126(5):1277-86. PubMed ID: 7520448
[TBL] [Abstract][Full Text] [Related]
14. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency.
Peschen M; Lahaye T; Hennig B; Weyl A; Simon JC; Vanscheidt W
Acta Derm Venereol; 1999 Jan; 79(1):27-32. PubMed ID: 10086854
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis.
Whitcup SM; DeBarge LR; Caspi RR; Harning R; Nussenblatt RB; Chan CC
Clin Immunol Immunopathol; 1993 May; 67(2):143-50. PubMed ID: 8100190
[TBL] [Abstract][Full Text] [Related]
16. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production.
Salomon B; Bluestone JA
J Immunol; 1998 Nov; 161(10):5138-42. PubMed ID: 9820482
[TBL] [Abstract][Full Text] [Related]
17. Expression of the adhesion molecules ICAM-1, VCAM-1, and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers.
Weyl A; Vanscheidt W; Weiss JM; Peschen M; Schopf E; Simon J
J Am Acad Dermatol; 1996 Mar; 34(3):418-23. PubMed ID: 8609252
[TBL] [Abstract][Full Text] [Related]
18. Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain.
Bashir R; Coakham H; Hochberg F
J Neurooncol; 1992 Feb; 12(2):103-10. PubMed ID: 1348529
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping and functional properties of anti-intercellular adhesion molecule-3 (CD50) monoclonal antibodies.
Bossy D; Buckley CD; Holness CL; Littler AJ; Murray N; Collins I; Simmons DL
Eur J Immunol; 1995 Feb; 25(2):459-65. PubMed ID: 7875209
[TBL] [Abstract][Full Text] [Related]
20. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibodies.
Herold KC; Vezys V; Gage A; Montag AG
Cell Immunol; 1994 Sep; 157(2):489-500. PubMed ID: 7915204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
